123
Views
5
CrossRef citations to date
0
Altmetric
Clinical Research Articles

Echocardiographic findings in kidney transplant patients with autosomal dominant polycystic kidney disease

, , &
Pages 416-419 | Received 11 Jun 2008, Published online: 18 Nov 2009

References

  • Hadimeri H, Johansson A-C, Haraldsson B, Nyberg G. Peritoneal dialysis in patients with autosomal dominant polycystic kidney disease. Perit Dial Int 1998; 18: 429–32
  • Hadimeri H, Nordén G, Friman S, Nyberg G. Adult dominant polycystic kidney disease in a kidney transplant population. Nephrol Dial Transpl 1997; 12: 1431–6
  • Hadimeri H, Lamm C, Nyberg G. Coronary aneurysms in patients with autosomal dominant polycystic kidney disease. J Am Soc Nephrol 1998; 9: 837–41
  • Hadimeri H, Hadimeri U, Attman P-O, Nyberg G. Dimensions of arteriovenous fistulas in patients with autosomal dominant polycystic kidney disease. Nephron 2000; 85: 50–3
  • Castiglioni G, Gibelli G, Milani S, Benelli R, Riegler P, Fasciolo F, et al. Cardiac valvular abnormalities in ADPKD. Contrib Nephrol 1995; 115: 159–62
  • Chauveau D, Pirson Y, Verellen-Dumoulin C, Macnicol A, Gonzalo A, Grünfeld J-P. Intracranial aneurysms in autosomal dominant polycystic kidney disease. Kidney Int 1994; 45: 1140–6
  • Rossetti, S, Chauveau, D, Kubly, V, Slezak, JM, Saggar-Malik, AK, Pei, Y, , et al. Association of mutation position in polycystic kidney disease 1 (PKD1) gene and development of a vascular phenotype. Lancet Jun 28, 2003;361:2196–201.
  • Torres VE, Holley KE, Offord KP. General features of autosomal dominant polycystic kidney disease. Problems in diagnosis and management of polycystic kidney disease, JJ Grantham, KD Gardner. Kidney Research Foundation, Kansas City 1985; 65–71
  • Paynter HE, Parnham A, Feest TG, Dudley CRK. Thoracic aortic dissection complicating autosomal dominant polycystic kidney disease. Nephrol Dial Transplant 1997; 12: 1711–3
  • Qian Q, Li M, Cai Y, Ward CJ, Somlo S, Harris PC, Torres VE. Analysis of the polycystins in aortic vascular smooth muscle cells. J Am Soc Nephrol 2003; 14(9)2280–7
  • Hossack KF, Leddy CL, Johnson AM, Schrier RW, Gabow PA. Echocardiographic findings in autosomal dominant polycystic kidney disease. N Engl J Med 1988; 319: 907–12
  • Leier CV, Baker PB, Kilman JW, Wooley CF. Cardiovascular abnormalities associated with adult polycystic kidney disease. Ann Intern Med 1984; 100: 683–8
  • Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantification in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978; 58: 1072–83
  • Teichholz LE, Kreulen T, Herman MV, Gorlin R. Problems in echocardiographic volume determinations: echocardiographic–angiographic correlations in the presence or absence of asynergy. Am J Cardiol 1976; 37: 7–11
  • Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986; 57: 450–8
  • Griffin MD, Torres VE, Grande JP, Kumar R. Immunolocalization of polycystin in human tissues and cultured cells. Proc Assoc Am Phys 1996; 108: 185–97
  • Peters DJM, van de Wal A, Spruit L, Saris JJ, Breuning MH, Bruijn JA, de Heer E. Cellular localization and tissue distribution of polycystin-1. J Pathol 1999; 188: 439–46
  • Ivy DD, Shaffer EM, Kimberling WJ, Dobin A, Gabow PA. Cardiovascular abnormalities in children with autosomal dominant polycystic kidney disease. J Am Soc Nephrol 1995; 5: 2032–6
  • Martinez-Vea A, Bardají A, Gutierrez C, Garcia C, Peralta C, Aguilera J, et al. Echocardiographic evaluation in patients with autosomal dominant polycystic kidney disease and end-stage renal disease. Am J Kidney Dis 1999; 34: 264–72
  • Ritz E, Zeier M, Schneider P, Jones E. Cardiovascular mortality of patients with polycystic kidney disease on dialysis: is there a lesson to learn?. Nephron 1994; 66: 125–8
  • Saggar-Malik AK, Missouris CG, Gill JS, Singer DRJ, Markandu ND, MacGregor GA. Left ventricular mass in normotensive subjects with autosomal dominant polycystic kidney disease. BMJ 1994; 309: 1617–8
  • Chapman AB, Johnson AM, Rainguet S, Hossack K, Gabow P, Schrier RW. Left ventricular hypertrophy in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 1997; 8: 1292–7
  • Valero FA, Martinez-Vea A, Bardají A, Gutierrez C, Garcia C, Richart C, Oliver JA. Ambulatory blood pressure and left ventricular mass in normotensive patients with autosomal dominant polycystic kidney disease. J Am Soc Nephrol 1999; 10: 1020–6
  • Perrone RD, Ruthazer R, Terrin NC. Survival after end-stage renal disease in autosomal dominant polycystic kidney disease: contribution of extrarenal complications to mortality. Am J Kidney Dis 2001; 38: 777–84
  • Marrón, B, Remón, C, Pérez-Fontán, M, Quirós, P, Ortíz, A. Benefits of preserving residual renal function in peritoneal dialysis. Kidney Int Suppl 2008;42–51.
  • Parfey PS, Harnett JD, Foley RN, Kent GM, Murray DC, Barre PE, Guttman RD. Impact of renal transplantation on uremic cardiomyopathy. Transplantation 1995; 60: 908–14
  • McGregor E, Jardine AG, Murray LS, Dargie HJ, Rodger RS, Junor BJ, et al. Pre-operative echocardiographic abnormalities and adverse outcome following renal transplantation. Nephrol Dial Transplant 1998; 13: 1499–505

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.